腹部深呼吸屏气进一步降低心脏剂量:一项前瞻性分析
22例左侧乳腺癌患者前瞻性入组,每例生成自由呼吸、胸部深呼吸屏气(T-DIBH)与腹部深呼吸屏气(A-DIBH)三种CT扫描下的3D-CRT与IMRT共六个计划。A-DIBH在3D-CRT和IMRT中均使心脏与左前降支冠状动脉剂量低于自由呼吸和T-DIBH;作者建议将A-DIBH的IMRT计划纳入左侧乳腺癌放疗日常流程。
要点
- 3D-CRT中A-DIBH的心脏平均剂量低于自由呼吸和T-DIBH。
- IMRT中A-DIBH的心脏平均剂量低于自由呼吸和T-DIBH。
- 作者建议将A-DIBH的IMRT计划纳入左侧乳腺癌放疗日常流程。
核心结论
- 3D-CRT与IMRT计划采用A-DIBH时心脏和左前降支冠状动脉剂量均低于自由呼吸与T-DIBH计划。
- 3D-CRT计划采用A-DIBH时同侧肺剂量低于自由呼吸与T-DIBH计划。
- IMRT计划采用A-DIBH时心脏、左前降支冠状动脉和同侧肺平均剂量均优于3D-CRT计划采用A-DIBH。
- 作者认为应将A-DIBH的IMRT计划纳入左侧乳腺癌放疗日常流程。
研究设计与样本
- 前瞻性研究,纳入22例左侧乳腺癌患者。
- 每例患者采集自由呼吸、T-DIBH和A-DIBH三种CT扫描,各生成3D-CRT与IMRT计划,共六个计划。
- 比较心脏、左前降支冠状动脉和同侧肺剂量,采用Wilcoxon符号秩检验。
主要发现
- 3D-CRT计划中自由呼吸、T-DIBH、A-DIBH的心脏平均剂量分别为2.89±1.30、1.67±0.90、1.34±0.43 Gy(均P<0.05)。
- 3D-CRT计划中自由呼吸、T-DIBH、A-DIBH的左前降支冠状动脉平均剂量分别为29.08±16.72、13.94±14.74、10.22±10.30 Gy(均P<0.05)。
- 3D-CRT计划中自由呼吸、T-DIBH、A-DIBH的同侧肺平均剂量分别为7.77±2.71、7.32±1.42、6.90±1.60 Gy(均P<0.05)。
- IMRT计划中自由呼吸、T-DIBH、A-DIBH的心脏平均剂量分别为1.96±2.25、1.37±0.44、1.18±0.26 Gy(均P<0.05)。
- IMRT计划中自由呼吸、T-DIBH、A-DIBH的左前降支冠状动脉平均剂量分别为16.10±7.45、8.6±6.60、7.35±5.42 Gy(均P<0.05)。
临床怎么用
- 作者认为,应将A-DIBH的IMRT计划纳入左侧乳腺癌放疗日常流程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep inspiration breath hold (DIBH) can be performed using different breathing maneuvers, such as DIBH with a thoracic breathing maneuver (T-DIBH) and DIBH with an abdominal breathing maneuver (A-DIBH). Dosimetric benefits of A-DIBH were investigated in the treatment of left-sided breast cancer radiotherapy (RT) with both 3-Dimensional conformal radiation therapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) techniques. METHODS: Twenty-two patients with left-sided breast cancer were enrolled in this study. 3D-CRT and IMRT plans were generated for each patient with three different CT scans of free breathing (FB), T-DIBH and A-DIBH. There were total of six treatment plans generated for each patient: FB_3D-CRT; TDIBH_3D-CRT; ADIBH_3D-CRT; FB-IMRT; TDIBH-IMRT; ADIBH-IMRT. Doses to the heart, left anterior descending coronary artery (LADCA), and ipsilateral lung were evaluated and compared using the Wilcoxon signed-rank test. RESULTS: The mean doses to the heart, LADCA and ipsilateral lung in 3D-CRT plans generated from 3D-CRT with FB, T-DIBH and A-DIBH were (2.89 ± 1.30), (1.67 ± 0.90) and (1.34 ± 0.43) Gy (all P < 0.05), respectively, with FB; (29.08 ± 16.72), (13.94 ± 14.74) and (10.22 ± 10.30) Gy (all P < 0.05), respectively, with T-DIBH; and (7.77 ± 2.71), (7.32 ± 1.42) and (6.90 ± 1.60) Gy (all P < 0.05), respectively, with A-DIBH. The mean doses to the heart, LADCA and ipsilateral lung in IMRT plans were generated from IMRT with FB, T-DIBH and A-DIBH were (1.96 ± 2.25), (1.37 ± 0.44) and (1.18 ± 0.26) Gy (all P < 0.05), respectively, with FB; (16.10 ± 7.45), (8.6 ± 6.60) and (7.35 ± 5.42) Gy (all P < 0.05), respectively, with T-DIBH; and (5.90 ± 2.24), (5.65 ± 1.58) and (5.62 ± 1.05) Gy (all P > 0.05), respectively, with A-DIBH. CONCLUSIONS: This study indicates that both 3D-CRT and IMRT plans with A-DIBH achieved lower cardiac and LADCA doses than plans with FB and T-DIBH; 3D-CRT plans with A-DIBH achieved lower ipsilateral lung doses than plans with FB and T-DIBH; and IMRT plans with A-DIBH had better outcomes than 3D-CRT plans with A-DIBH with respect to the mean dose to the heart, LADCA and ipsilateral lung. IMRT plans with A-DIBH should be incorporated into the daily routine for left-sided breast RT.
引用
- Zhao F, Shen J, Lu Z, et al. Abdominal DIBH reduces the cardiac dose even further: a prospective analysis. Radiat Oncol. 2018. PMID: 29929560. doi:10.1186/s13014-018-1062-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。